Glenmark Pharmaceuticals Inc. issued a recall for some of its Potassium Chloride Extended-Release Capsules over a "failed dissolution" that may cause heart attacks.

You can also take potassium chloride through an extended-release tablet, extended-release capsule, injectable, oral solution, and powder for oral solution. Before you start or stop taking the ...

Glenmark Pharmaceuticals has received final approval from the US health regulator for Potassium Chloride Extended Release Tablets, used in treating low levels of potassium in blood.

Potassium Chloride Extended-Release Capsules are used for the treatment of patients with low potassium (hypokalemia). The capsules are packaged in bottles of 100-count (NDC 68462-357-01) and 500 ...

Shares of Strides Pharma Science rose 3 percent intraday Wednesday as company received United States Food & Drug Administration (USFDA) approval for Potassium Chloride extended release tablets ...

Citing IQVIA Health data, Granules said Potassium Chloride extended release tablets had US generic sales of approximately USD 204 million for the most recent 12 months ending in August 2020.

Company's current portfolio consists of 117 products authorised for distribution in the US marketplace and 61 ANDA pending approval with the USFDA.

The Food and Drug Administration approved Glenmark Pharamceuticals' potassium chloride tablets. The tablets, used to treat a potassium deficiency, are a generic version of K Dur tablets produced ...

The tablets, used to treat a potassium deficiency, are a generic version of K Dur tablets produced by Merck Sharp & Dohm, a subsidiary of Kenilworth, N.J.-based Merck. The K Dur tablets reported ...